Search research articles
Contact Us
Filters
Showing results (61-70 of 113) with videos related to
Page
of 12
Sort By:
The American Journal of Medicine
|
May 6, 2019
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis
Craig I Coleman, Reinhold Kreutz, Nitesh A Sood, et al.
Journal of Internal Medicine
|
May 1, 2025
Elevated lipoprotein(a) and progression of aortic stenosis measured by Doppler echocardiography: A population-based cohort study
Jonas Brinck, Karin Littmann, Daniel Eriksson Hogling, et al.
Scandinavian Journal of Immunology
|
February 15, 2020
Screening for autoantibody targets in post-vaccination narcolepsy using proteome arrays
Alexander Lind, Daniel Eriksson, Omar Akel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 25, 2019
Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease
Craig I Coleman, William L Baker, Anna-Katharina Meinecke, et al.
Pharmacotherapy
|
January 1, 2019
Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
Brandon K Martinez, William L Baker, Nitesh A Sood, et al.
Oncotarget
|
April 7, 2016
High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6
Guang-Liang Chen, Yubin Luo, Daniel Eriksson, et al.
Atherosclerosis
|
June 24, 2026
Optimizing lipoprotein(a) testing for immediate clinical impact in primary prevention
Elias Björnson, Emil Hagström, Karin Littmann, et al.
Diabetes, Obesity & Metabolism
|
May 18, 2019
Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes
William L Baker, Jan Beyer-Westendorf, Thomas J Bunz, et al.
Diabetes Care
|
November 18, 2016
Long-term Protective Changes in Adipose Tissue After Gastric Bypass
Johan Hoffstedt, Daniel P Andersson, Daniel Eriksson Hogling, et al.
European Heart Journal Open
|
March 15, 2024
Relation among hypertriglyceridaemia, cardiometabolic disease, and hereditary factors-design and rationale of the Stockholm hyperTRIglyceridaemia REGister study
Daniel P Andersson, Karin Littmann, Gustav Kindborg, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 113) with videos related to
Sort By:
Page
of 12
The American Journal of Medicine
|
May 6, 2019
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis
Craig I Coleman, Reinhold Kreutz, Nitesh A Sood, et al.
Journal of Internal Medicine
|
May 1, 2025
Elevated lipoprotein(a) and progression of aortic stenosis measured by Doppler echocardiography: A population-based cohort study
Jonas Brinck, Karin Littmann, Daniel Eriksson Hogling, et al.
Scandinavian Journal of Immunology
|
February 15, 2020
Screening for autoantibody targets in post-vaccination narcolepsy using proteome arrays
Alexander Lind, Daniel Eriksson, Omar Akel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 25, 2019
Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease
Craig I Coleman, William L Baker, Anna-Katharina Meinecke, et al.
Pharmacotherapy
|
January 1, 2019
Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
Brandon K Martinez, William L Baker, Nitesh A Sood, et al.
Oncotarget
|
April 7, 2016
High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6
Guang-Liang Chen, Yubin Luo, Daniel Eriksson, et al.
Atherosclerosis
|
June 24, 2026
Optimizing lipoprotein(a) testing for immediate clinical impact in primary prevention
Elias Björnson, Emil Hagström, Karin Littmann, et al.
Diabetes, Obesity & Metabolism
|
May 18, 2019
Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes
William L Baker, Jan Beyer-Westendorf, Thomas J Bunz, et al.
Diabetes Care
|
November 18, 2016
Long-term Protective Changes in Adipose Tissue After Gastric Bypass
Johan Hoffstedt, Daniel P Andersson, Daniel Eriksson Hogling, et al.
European Heart Journal Open
|
March 15, 2024
Relation among hypertriglyceridaemia, cardiometabolic disease, and hereditary factors-design and rationale of the Stockholm hyperTRIglyceridaemia REGister study
Daniel P Andersson, Karin Littmann, Gustav Kindborg, et al.
Page
of 12